A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Kedrion S.p.A.
Life Molecular Imaging SA
Prothena Biosciences Ltd.
INSYS Therapeutics Inc